Montag & Associates’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$102K	Hold	194	–	–	﹤0.01%	501
2025 Q4	$113K	Hold	194	–	–	0.01%	494
2025 Q3	$89K	Hold	194	–	–	﹤0.01%	506
2025 Q2	$58.7K	Hold	194	–	–	﹤0.01%	557
2025 Q1	$64.3K	Hold	194	–	–	﹤0.01%	565
2024 Q4	$59.9K	Hold	194	–	–	﹤0.01%	575
2024 Q3	$41.2K	Hold	194	–	–	﹤0.01%	640
2024 Q2	$54.4K	Hold	194	–	–	﹤0.01%	580
2024 Q1	$51.8K	Hold	194	–	–	﹤0.01%	594
2023 Q4	$44.9K	Hold	194	–	–	﹤0.01%	597
2023 Q3	$28.3K	Buy	194 +134	+223%	+$25.2K	﹤0.01%	631
2023 Q2	$13.9K	Hold	60	–	–	﹤0.01%	715
2023 Q1	$14.5K	Hold	60	–	–	﹤0.01%	699
2022 Q4	$17.4K	Sell	60 -50	-45%	-$4.89K	﹤0.01%	678
2022 Q3	$7K	Hold	110	–	–	﹤0.01%	764
2022 Q2	$8K	Sell	110 -30	-21%	-$2.21K	﹤0.01%	712
2022 Q1	$14K	Hold	140	–	–	﹤0.01%	694
2021 Q4	$12K	Hold	140	–	–	﹤0.01%	714
2021 Q3	$11K	Hold	140	–	–	﹤0.01%	722
2021 Q2	$14K	Hold	140	–	–	﹤0.01%	697
2021 Q1	$16K	Hold	140	–	–	﹤0.01%	685
2020 Q4	$16K	Buy	+140	New	+$17.1K	﹤0.01%	662